Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12323)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 18, 2015 (publication date) through Dec 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol 2015; 7(5): 777-786 [PMID: 25914778 DOI: 10.4254/wjh.v7.i5.777] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3249/full/v7/i5/777.htm |
| Number | Citing Articles |
| 1 |
Anika Wranke, Heiner Wedemeyer. Antiviral therapy of hepatitis delta virus infection — progress and challenges towards cure. Current Opinion in Virology 2016; 20: 112 doi: 10.1016/j.coviro.2016.10.002
|
| 2 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|
| 3 |
Mehmet Çelik, Mehmet Reşat Ceylan, Yusuf Arslan, Nevin Güler Dinçer, Sevil Alkan. BIBLIOMETRIC ANALYSIS OF PUBLICATIONS ON HEPATITIS D VIRUS PUBLISHED IN 1984–2022. Central Asian Journal of Medical Hypotheses and Ethics 2023; 4(1): 22 doi: 10.47316/cajmhe.2023.4.1.02
|
| 4 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 5 |
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, Yujin Hoshida. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. Journal of Hepatology 2018; 68(3): 526 doi: 10.1016/j.jhep.2017.09.016
|
| 6 |
Francesco Paolo Russo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra, Fabio Farinati. Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?. International Journal of Molecular Sciences 2022; 23(1): 500 doi: 10.3390/ijms23010500
|
| 7 |
Ye Fan, Xiaofeng Qian, Chuanyong Zhang. U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population. Tumor Biology 2016; 37(11): 14629 doi: 10.1007/s13277-016-5352-z
|
| 8 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 9 |
Patrizia Farci, Grazia Anna Niro, Fausto Zamboni, Giacomo Diaz. Hepatitis D Virus and Hepatocellular Carcinoma. Viruses 2021; 13(5): 830 doi: 10.3390/v13050830
|
| 10 |
Vincent Soriano, Antonio Aguilera. Hepatitis Delta Enters a New Therapeutic Era. The Journal of Infectious Diseases 2018; 217(8): 1173 doi: 10.1093/infdis/jix658
|
| 11 |
Marc Ringehan, Jane A. McKeating, Ulrike Protzer. Viral hepatitis and liver cancer. Philosophical Transactions of the Royal Society B: Biological Sciences 2017; 372(1732): 20160274 doi: 10.1098/rstb.2016.0274
|
| 12 |
Vincent Soriano, Pablo Labarga, Carmen de Mendoza, José V Fernández-Montero, Ana Treviño, Laura Benítez-Gutiérrez, José M Peña, Pablo Barreiro. Delta Hepatitis: New Approaches to Therapy. Future Virology 2016; 11(3): 197 doi: 10.2217/fvl-2015-0009
|
| 13 |
Pinar Erkekoglu, Suna Sabuncuoğlu. Liver Cancer in the Middle East. 2021; : 31 doi: 10.1007/978-3-030-78737-0_3
|
| 14 |
Thomas Tu, Sandra Bühler, Ralf Bartenschlager. Chronic viral hepatitis and its association with liver cancer. Biological Chemistry 2017; 398(8): 817 doi: 10.1515/hsz-2017-0118
|
| 15 |
Gulnara Aghayeva, Mario Rizzetto, Necati Ormeci, Adela Turcanu, Zaigham Abbas, Essam Bedewy. Hepatology. 2025; : 655 doi: 10.1016/B978-0-443-26710-9.00023-7
|
| 16 |
Theo Heller, Christopher Koh, Jeffrey S. Glenn. Zakim and Boyer's Hepatology. 2018; : 501 doi: 10.1016/B978-0-323-37591-7.00034-3
|
| 17 |
Lihua Wang, Zheng Zhu, Lei Han, Liqian Zhao, Jialei Weng, Hongbao Yang, Shijia Wu, Kaiyuan Chen, Liang Wu, Tongke Chen. A curcumin derivative, WZ35, suppresses hepatocellular cancer cell growthviadownregulating YAP-mediated autophagy. Food & Function 2019; 10(6): 3748 doi: 10.1039/C8FO02448K
|
| 18 |
Haris Muhammad, Aniqa Tehreem, Muhammad Baraa Hammami, Peng-Sheng Ting, Ramzan Idilman, Ahmet Gurakar. Hepatitis D virus and liver transplantation: Indications and outcomes. World Journal of Hepatology 2021; 13(3): 291-299 doi: 10.4254/wjh.v13.i3.291
|
| 19 |
Ricardo Flores, Robert A Owens, John Taylor. Pathogenesis by subviral agents: viroids and hepatitis delta virus. Current Opinion in Virology 2016; 17: 87 doi: 10.1016/j.coviro.2016.01.022
|
| 20 |
Louis Shekhtman, Sarah Duehren, Ohad Etzion, Scott J. Cotler, Harel Dahari. Hepatitis D Virus and HBsAg Dynamics in the era of new Antiviral Treatments. Current Gastroenterology Reports 2023; 25(12): 401 doi: 10.1007/s11894-023-00901-9
|
| 21 |
Anaïs Vallet‐Pichard, Stanislas Pol. Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2021; 53(11): 1166 doi: 10.1111/apt.16356
|
| 22 |
Rocío González Grande, Inmaculada Santaella Leiva, Susana López Ortega, Miguel Jiménez Pérez. Present and future management of viral hepatitis. World Journal of Gastroenterology 2021; 27(47): 8081-8102 doi: 10.3748/wjg.v27.i47.8081
|
| 23 |
Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40: 101342 doi: 10.1016/j.nanoso.2024.101342
|
| 24 |
Mario Rizzetto. Clinical Epidemiology of Chronic Liver Diseases. 2019; : 135 doi: 10.1007/978-3-319-94355-8_11
|
| 25 |
A. Baskiran, A. Atay, D. Y. Baskiran, S. Akbulut. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review. Journal of Gastrointestinal Cancer 2021; 52(4): 1192 doi: 10.1007/s12029-021-00714-x
|
| 26 |
Shuling Wu, Liu Yang, Xiaoyue Bi, Yanjie Lin, Wen Deng, Tingting Jiang, Minghui Li, Yao Xie. Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus. Gastroenterology & Endoscopy 2023; 1(1): 5 doi: 10.1016/j.gande.2022.10.001
|
| 27 |
Mahbobeh Hajiabdolbaghi, Zahra Abdiliae, Jaleh Bayani, Mehdi Qaempanah, Fereshteh Ghiasvand. Characteristics of Hepatitis B and D Co-infection: A Descriptive Study. Hepatitis Monthly 2021; 21(1) doi: 10.5812/hepatmon.101630
|
| 28 |
J. -F. Blanc. Carcinome hépatocellulaire : nouveautés épidémiologiques et démarche diagnostique. Oncologie 2017; 19(5-6): 135 doi: 10.1007/s10269-017-2709-x
|
| 29 |
Yingying Lin, Ting Qiu, Guifeng Wei, Yueyue Que, Wenxin Wang, Yichao Kong, Tian Xie, Xiabin Chen. Role of Histone Post-Translational Modifications in Inflammatory Diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.852272
|
| 30 |
Elham Shirvani-Dastgerdi, Robert E Schwartz, Alexander Ploss. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Current Opinion in Virology 2016; 20: 1 doi: 10.1016/j.coviro.2016.07.009
|
| 31 |
Mario Rizzetto, Antonina Smedile, Alessia Ciancio. Clinical Virology. 2016; : 1409 doi: 10.1128/9781555819439.ch58
|
| 32 |
Christopher Koh, Theo Heller, Jeffrey S. Glenn. Pathogenesis of and New Therapies for Hepatitis D. Gastroenterology 2019; 156(2): 461 doi: 10.1053/j.gastro.2018.09.058
|
| 33 |
Ben L Da, Theo Heller, Christopher Koh. Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterology Report 2019; 7(4): 231 doi: 10.1093/gastro/goz023
|
| 34 |
Vincent Soriano, Kenneth E. Sherman, Pablo Barreiro. Hepatitis delta and HIV infection. AIDS 2017; 31(7): 875 doi: 10.1097/QAD.0000000000001424
|
| 35 |
Yan Wang, Jeffrey S. Glenn, Mark A. Winters, Li-ping Shen, Ingrid Choong, Ya-lun Shi, Sheng-li Bi, Li-ying Ma, Hui Zeng, Fu-jie Zhang. A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection. Diagnostic Microbiology and Infectious Disease 2018; 92(2): 112 doi: 10.1016/j.diagmicrobio.2018.05.016
|
| 36 |
Jing Li, Yan Zhang, Bing Luo. Effects of Exosomal Viral Components on the Tumor Microenvironment. Cancers 2022; 14(14): 3552 doi: 10.3390/cancers14143552
|
| 37 |
Patrizia Farci, Grazia Anna Niro. Sherlock's Diseases of the Liver and Biliary System. 2018; : 421 doi: 10.1002/9781119237662.ch22
|
| 38 |
Jennifer Mbamalu Chinenye, Mercy Ekejindu Ifeoma, Bessie Enweani-Nwokelo Ifeoma, Ikechukwu Okeke Obiefuna, Amaechi Ofodile Chukwudi, Okorafor Kalu Stephen. Frequency of hepatitis C and D virus among chronic hepatitis B virus carriers in a Nigerian tertiary hospital. Journal of Public Health and Epidemiology 2022; 14(1): 10 doi: 10.5897/JPHE2021.1367
|
| 39 |
Frédéric Le Gal, Ségolène Brichler, Roland Sahli, Sylvie Chevret, Emmanuel Gordien. First international external quality assessment for hepatitis delta virus RNA quantification in plasma. Hepatology 2016; 64(5): 1483 doi: 10.1002/hep.28772
|
| 40 |
Federico Costante, Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Tarik Asselah, Francesca Romana Ponziani. Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. Journal of Hepatocellular Carcinoma 2023; : 713 doi: 10.2147/JHC.S384751
|
| 41 |
Haris Muhammad, Duha Zaffar, Aniqa Tehreem, Peng-Sheng Ting, Cem Simsek, Hale Gokcan, Ahmet Gurakar, Ramazan Idilman. HBV/HDV management after liver transplantation: Review. Journal of Liver Transplantation 2021; 4: 100046 doi: 10.1016/j.liver.2021.100046
|
| 42 |
Tuvshinjargal Chimed, Tuvshingerel Sandagdorj, Ariana Znaor, Mathieu Laversanne, Badamsuren Tseveen, Purevsuren Genden, Freddie Bray. Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008–12. International Journal of Cancer 2017; 140(2): 302 doi: 10.1002/ijc.30463
|
| 43 |
Christopher Koh, Ben L. Da, Jeffrey S. Glenn. HBV/HDV Coinfection. Clinics in Liver Disease 2019; 23(3): 557 doi: 10.1016/j.cld.2019.04.005
|
| 44 |
Vivek Kumar Soni, Yashwant Kumar Ratre, Arundhati Mehta, Ashwini Kumar Dixit, Mrigendra Dwivedi, Dhananjay Shukla, Ajay Kumar, Naveen Kumar Vishvakarma. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 141 doi: 10.1016/B978-0-323-99283-1.00007-0
|
| 45 |
Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation. Hepatology International 2020; 14(5): 869 doi: 10.1007/s12072-020-10085-3
|
| 46 |
Zaigham Abbas, Minaam Abbas. An Insight Into the Factors Affecting the Prevalence and Natural History of Hepatitis D. Cureus 2023; doi: 10.7759/cureus.43362
|
| 47 |
Xin Ye, Chise Tateno, Emily P. Thi, Masakazu Kakuni, Nicholas M. Snead, Yuji Ishida, Trisha R. Barnard, Michael J. Sofia, Takashi Shimada, Amy C. H. Lee. Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model. ACS Infectious Diseases 2019; 5(5): 738 doi: 10.1021/acsinfecdis.8b00192
|
| 48 |
Parvine Basimane-Bisimwa, Giscard Wilfried Koyaweda, Edgarthe Ngaïganam, Ulrich Vickos, Ornella Anne Demi Sibiro, Brice Martial Yambiyo, Benjamin Seydou Sombié, Pulchérie Pélembi, Sandrine Moussa, Claudine Bekondi, Tamara Giles-Vernick, Alexandre Manirakiza, Muriel Vray, Narcisse Patrice Joseph Komas, Pierre Roques. Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic. PLOS ONE 2024; 19(5): e0291155 doi: 10.1371/journal.pone.0291155
|
| 49 |
Raffaella Romeo, Arnolfo Petruzziello, Eve Isabel Pecheur, Floriana Facchetti, Riccardo Perbellini, Enrico Galmozzi, Najeeb Ullah Khan, Lucia Di Capua, Rocco Sabatino, Gerardo Botti, Giovanna Loquercio. Hepatitis delta virus and hepatocellular carcinoma: an update. Epidemiology and Infection 2018; 146(13): 1612 doi: 10.1017/S0950268818001942
|
| 50 |
Caterina Sagnelli, Evangelista Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Laura Occhiello, Nicola Coppola. HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges. Life 2021; 11(2): 169 doi: 10.3390/life11020169
|
| 51 |
Tarik Asselah, Vladimir Chulanov, Pietro Lampertico, Heiner Wedemeyer, Adrian Streinu-Cercel, Victor Pântea, Stefan Lazar, Gheorghe Placinta, George S. Gherlan, Pavel Bogomolov, Tatyana Stepanova, Viacheslav Morozov, Vladimir Syutkin, Olga Sagalova, Dmitry Manuilov, Renee-Claude Mercier, Lei Ye, Ben L. Da, Grace Chee, Audrey H. Lau, Anu Osinusi, Marc Bourliere, Vlad Ratziu, Stanislas Pol, Marie-Noëlle Hilleret, Fabien Zoulim. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D. New England Journal of Medicine 2024; 391(2): 133 doi: 10.1056/NEJMoa2314134
|
| 52 |
Mianzhi Chen, Dan Du, Wen Zheng, Mingheng Liao, Lu Zhang, Ge Liang, Meng Gong. Small hepatitis delta antigen selectively binds to target mRNA in hepatic cells: a potential mechanism by which hepatitis D virus downregulates glutathioneS-transferase P1 and induces liver injury and hepatocarcinogenesis. Biochemistry and Cell Biology 2019; 97(2): 130 doi: 10.1139/bcb-2017-0321
|
| 53 |
Parag Mahale, Peter Aka, Xiaohua Chen, Ruth M. Pfeiffer, Ping Liu, Sarah Groover, Maimuna Mendy, Ramou Njie, James J. Goedert, Gregory D. Kirk, Jeffrey S. Glenn, Thomas R. O'Brien. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia. Journal of Viral Hepatitis 2019; 26(6): 738 doi: 10.1111/jvh.13065
|